CollPlant Biotechnologies (CLGN) Change in Cash (2018 - 2025)
CollPlant Biotechnologies (CLGN) posted Change in Cash of -$3.0 million for Q4 2025, down 2.39% on a QoQ basis from -$2.9 million in Q3 2025, and up 14.62% year-over-year from -$2.6 million in Q4 2024.
CollPlant Biotechnologies (CLGN) Change in Cash (2018 - 2025) Analysis & Trends
CollPlant Biotechnologies' Change in Cash history runs 8 years deep, the most recent figure standing at -$3.0 million for Q4 2025.
- Quarterly Change in Cash rose 14.62% year-over-year to -$3.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$8.6 million (up 41.71% YoY) and the FY2025 annual result came in at -$6.3 million, up 57.21% from the prior year.
- Change in Cash was -$3.0 million for Q4 2025 at CollPlant Biotechnologies, down from -$2.9 million in the prior quarter.
- Across five years, Change in Cash topped out at $28.1 million in Q1 2022 and bottomed at -$16.1 million in Q4 2021.
- A 5-year average of $1.3 million and a median of -$2.9 million in 2025 frame the typical range for Change in Cash.
- Peak annual rise in Change in Cash reached 794.62% in 2021, while the deepest fall reached 3093.07% in 2021.
- CollPlant Biotechnologies' Change in Cash stood at -$16.1 million in 2021, then jumped by 206.03% to $17.1 million in 2022, then plunged by 114.73% to -$2.5 million in 2023, then sank by 37.49% to -$3.5 million in 2024, then advanced by 14.62% to -$3.0 million in 2025.
- Business Quant data shows CLGN's Change in Cash at -$3.0 million in Q4 2025, -$2.9 million in Q3 2025, and $699000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.44 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 243.78 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 57.19 Mn |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.96 Mn |
| Sep 30, 2025 | -2.89 Mn |
| Jun 30, 2025 | 699,000.00 |
| Dec 31, 2024 | -3.46 Mn |
| Sep 30, 2024 | -3.55 Mn |
| Jun 30, 2024 | -4.31 Mn |
| Mar 31, 2024 | -3.45 Mn |
| Dec 31, 2023 | -2.52 Mn |
| Sep 30, 2023 | 6.62 Mn |
| Jun 30, 2023 | -4.21 Mn |
| Mar 31, 2023 | -3.07 Mn |
| Dec 31, 2022 | 17.10 Mn |
| Sep 30, 2022 | -2.78 Mn |
| Jun 30, 2022 | -5.02 Mn |
| Mar 31, 2022 | 28.15 Mn |
| Dec 31, 2021 | -16.13 Mn |
| Sep 30, 2021 | 11.82 Mn |
| Jun 30, 2021 | -2.30 Mn |
| Mar 31, 2021 | 16.45 Mn |
| Dec 31, 2020 | -505,000.00 |